FDA

“Right to Try” Marks New Era in the Treatment of Terminally Ill Patients

The Right to Try Act represents an important step toward helping dying patients with little recourse.

Groups of a Feather Regulate Together

A flock of regulators and industry representatives have a seat at the turkey-regulating table.

Proposed Rule Aims to Make Drug Pricing More Transparent

A proposed requirement to display drug list prices in advertisements draws controversy.

How State and Federal Food Regulations Can—and Should—Work Together

Experts argue that gaps in federal food safety rules require state governments to step up.

Regulatory Collaboration Is Key to Public Health Success

Federal health agencies should work together to address public health problems.

Invoking a Right to Try in Regenerative Medicine

Scholars caution against using the Right to Try Act to skirt regulation for regenerative therapies.

FDA Reform Needs to Look More Like Tax Reform

U.S. regulators should model the medical device classification process on recent tax reform.

Responding to Anti-Regulatory Tropes

Marchand’s argument questions key regulatory processes and ignores the net benefits of regulation.

Regulatory Process in Dire Need of Reform

EPA exemplifies how agency rulemaking pushes the boundaries of lawful policymaking.

How Regulatory Agencies Undervalue Life

Agencies should boost penalties for fatal rule violations to match the value of a statistical life.

How Regulation Can Improve Surgery

Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.

Gene Editing of Human Embryos Prompts Calls For Regulation

Despite ethical concerns, scholar argues that gene editing of human embryos should not be banned.